nodes	percent_of_prediction	percent_of_DWPC	metapath
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.00295	0.0474	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00184	0.0296	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—SSTR3—pancreatic cancer	0.00175	0.0282	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—SSTR1—pancreatic cancer	0.00168	0.027	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—PPY—pancreatic cancer	0.00165	0.0265	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—SSTR2—pancreatic cancer	0.00162	0.026	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.0015	0.0241	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—PRLHR—pancreatic cancer	0.00125	0.0201	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—CNR2—pancreatic cancer	0.00118	0.019	CbGpPWpGaD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.00111	0.0179	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—SSTR3—pancreatic cancer	0.00106	0.0171	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—SSTR1—pancreatic cancer	0.00102	0.0164	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—PPY—pancreatic cancer	0.000997	0.016	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—SSTR2—pancreatic cancer	0.000979	0.0157	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CCKBR—pancreatic cancer	0.000945	0.0152	CbGpPWpGaD
Vigabatrin—Breast disorder—Epirubicin—pancreatic cancer	0.00094	0.001	CcSEcCtD
Vigabatrin—Constipation—Irinotecan—pancreatic cancer	0.000938	0.001	CcSEcCtD
Vigabatrin—Pain—Irinotecan—pancreatic cancer	0.000938	0.001	CcSEcCtD
Vigabatrin—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000937	0.000999	CcSEcCtD
Vigabatrin—Mental disorder—Docetaxel—pancreatic cancer	0.000935	0.000997	CcSEcCtD
Vigabatrin—Somnolence—Fluorouracil—pancreatic cancer	0.000934	0.000996	CcSEcCtD
Vigabatrin—Nasopharyngitis—Epirubicin—pancreatic cancer	0.00093	0.000992	CcSEcCtD
Vigabatrin—Face oedema—Doxorubicin—pancreatic cancer	0.000929	0.000991	CcSEcCtD
Vigabatrin—Malnutrition—Docetaxel—pancreatic cancer	0.000929	0.00099	CcSEcCtD
Vigabatrin—Decreased appetite—Gemcitabine—pancreatic cancer	0.000929	0.00099	CcSEcCtD
Vigabatrin—Dyspepsia—Fluorouracil—pancreatic cancer	0.000924	0.000986	CcSEcCtD
Vigabatrin—Nausea—Tamoxifen—pancreatic cancer	0.000923	0.000984	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000922	0.000983	CcSEcCtD
Vigabatrin—Fatigue—Gemcitabine—pancreatic cancer	0.000921	0.000982	CcSEcCtD
Vigabatrin—GABBR1—G alpha (i) signalling events—SST—pancreatic cancer	0.00092	0.0148	CbGpPWpGaD
Vigabatrin—Pain—Gemcitabine—pancreatic cancer	0.000913	0.000974	CcSEcCtD
Vigabatrin—Constipation—Gemcitabine—pancreatic cancer	0.000913	0.000974	CcSEcCtD
Vigabatrin—Nausea—Erlotinib—pancreatic cancer	0.000913	0.000974	CcSEcCtD
Vigabatrin—Decreased appetite—Fluorouracil—pancreatic cancer	0.000913	0.000973	CcSEcCtD
Vigabatrin—Mood swings—Doxorubicin—pancreatic cancer	0.000912	0.000972	CcSEcCtD
Vigabatrin—Diarrhoea—Sunitinib—pancreatic cancer	0.000911	0.000971	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000907	0.000967	CcSEcCtD
Vigabatrin—Abdominal distension—Epirubicin—pancreatic cancer	0.000905	0.000965	CcSEcCtD
Vigabatrin—Ataxia—Doxorubicin—pancreatic cancer	0.000905	0.000965	CcSEcCtD
Vigabatrin—Feeling abnormal—Irinotecan—pancreatic cancer	0.000904	0.000963	CcSEcCtD
Vigabatrin—Influenza—Epirubicin—pancreatic cancer	0.000899	0.000959	CcSEcCtD
Vigabatrin—Back pain—Docetaxel—pancreatic cancer	0.000898	0.000958	CcSEcCtD
Vigabatrin—Pain—Fluorouracil—pancreatic cancer	0.000898	0.000958	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000897	0.000956	CcSEcCtD
Vigabatrin—Muscle spasms—Docetaxel—pancreatic cancer	0.000893	0.000952	CcSEcCtD
Vigabatrin—Dizziness—Sunitinib—pancreatic cancer	0.00088	0.000939	CcSEcCtD
Vigabatrin—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00088	0.000939	CcSEcCtD
Vigabatrin—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000879	0.000937	CcSEcCtD
Vigabatrin—Breast disorder—Doxorubicin—pancreatic cancer	0.00087	0.000927	CcSEcCtD
Vigabatrin—Body temperature increased—Irinotecan—pancreatic cancer	0.000867	0.000924	CcSEcCtD
Vigabatrin—Abdominal pain—Irinotecan—pancreatic cancer	0.000867	0.000924	CcSEcCtD
Vigabatrin—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000867	0.000924	CcSEcCtD
Vigabatrin—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000865	0.000923	CcSEcCtD
Vigabatrin—Bronchitis—Epirubicin—pancreatic cancer	0.000865	0.000922	CcSEcCtD
Vigabatrin—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000861	0.000918	CcSEcCtD
Vigabatrin—Anaemia—Docetaxel—pancreatic cancer	0.000858	0.000915	CcSEcCtD
Vigabatrin—GABBR1—G alpha (i) signalling events—CNR1—pancreatic cancer	0.000849	0.0137	CbGpPWpGaD
Vigabatrin—Vomiting—Sunitinib—pancreatic cancer	0.000846	0.000902	CcSEcCtD
Vigabatrin—Body temperature increased—Gemcitabine—pancreatic cancer	0.000844	0.0009	CcSEcCtD
Vigabatrin—Rash—Sunitinib—pancreatic cancer	0.000839	0.000895	CcSEcCtD
Vigabatrin—Dermatitis—Sunitinib—pancreatic cancer	0.000839	0.000894	CcSEcCtD
Vigabatrin—Abdominal distension—Doxorubicin—pancreatic cancer	0.000837	0.000893	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000836	0.000891	CcSEcCtD
Vigabatrin—Urticaria—Fluorouracil—pancreatic cancer	0.000834	0.00089	CcSEcCtD
Vigabatrin—Headache—Sunitinib—pancreatic cancer	0.000834	0.000889	CcSEcCtD
Vigabatrin—Influenza—Doxorubicin—pancreatic cancer	0.000832	0.000887	CcSEcCtD
Vigabatrin—Body temperature increased—Fluorouracil—pancreatic cancer	0.00083	0.000885	CcSEcCtD
Vigabatrin—Weight increased—Epirubicin—pancreatic cancer	0.000818	0.000872	CcSEcCtD
Vigabatrin—Cough—Docetaxel—pancreatic cancer	0.00081	0.000864	CcSEcCtD
Vigabatrin—Hypersensitivity—Irinotecan—pancreatic cancer	0.000808	0.000861	CcSEcCtD
Vigabatrin—Pneumonia—Epirubicin—pancreatic cancer	0.000806	0.00086	CcSEcCtD
Vigabatrin—Convulsion—Docetaxel—pancreatic cancer	0.000805	0.000858	CcSEcCtD
Vigabatrin—Drowsiness—Epirubicin—pancreatic cancer	0.000802	0.000855	CcSEcCtD
Vigabatrin—Infestation—Epirubicin—pancreatic cancer	0.000802	0.000855	CcSEcCtD
Vigabatrin—Infestation NOS—Epirubicin—pancreatic cancer	0.000802	0.000855	CcSEcCtD
Vigabatrin—Bronchitis—Doxorubicin—pancreatic cancer	0.0008	0.000853	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000795	0.000847	CcSEcCtD
Vigabatrin—Arthralgia—Docetaxel—pancreatic cancer	0.000791	0.000843	CcSEcCtD
Vigabatrin—Chest pain—Docetaxel—pancreatic cancer	0.000791	0.000843	CcSEcCtD
Vigabatrin—Myalgia—Docetaxel—pancreatic cancer	0.000791	0.000843	CcSEcCtD
Vigabatrin—Nausea—Sunitinib—pancreatic cancer	0.000791	0.000843	CcSEcCtD
Vigabatrin—Asthenia—Irinotecan—pancreatic cancer	0.000787	0.000839	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000786	0.000838	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000785	0.000837	CcSEcCtD
Vigabatrin—Conjunctivitis—Epirubicin—pancreatic cancer	0.000779	0.000831	CcSEcCtD
Vigabatrin—Urinary tract infection—Epirubicin—pancreatic cancer	0.000779	0.000831	CcSEcCtD
Vigabatrin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000774	0.000825	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000773	0.000824	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—SCT—pancreatic cancer	0.000771	0.0124	CbGpPWpGaD
Vigabatrin—Asthenia—Gemcitabine—pancreatic cancer	0.000766	0.000817	CcSEcCtD
Vigabatrin—Confusional state—Docetaxel—pancreatic cancer	0.000764	0.000815	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000758	0.000808	CcSEcCtD
Vigabatrin—Oedema—Docetaxel—pancreatic cancer	0.000758	0.000808	CcSEcCtD
Vigabatrin—Weight increased—Doxorubicin—pancreatic cancer	0.000757	0.000807	CcSEcCtD
Vigabatrin—Pruritus—Gemcitabine—pancreatic cancer	0.000756	0.000806	CcSEcCtD
Vigabatrin—Infection—Docetaxel—pancreatic cancer	0.000753	0.000803	CcSEcCtD
Vigabatrin—Sinusitis—Epirubicin—pancreatic cancer	0.000752	0.000802	CcSEcCtD
Vigabatrin—Diarrhoea—Irinotecan—pancreatic cancer	0.00075	0.0008	CcSEcCtD
Vigabatrin—Pneumonia—Doxorubicin—pancreatic cancer	0.000746	0.000795	CcSEcCtD
Vigabatrin—Nervous system disorder—Docetaxel—pancreatic cancer	0.000743	0.000793	CcSEcCtD
Vigabatrin—Pruritus—Fluorouracil—pancreatic cancer	0.000743	0.000792	CcSEcCtD
Vigabatrin—Infestation NOS—Doxorubicin—pancreatic cancer	0.000742	0.000791	CcSEcCtD
Vigabatrin—Infestation—Doxorubicin—pancreatic cancer	0.000742	0.000791	CcSEcCtD
Vigabatrin—Drowsiness—Doxorubicin—pancreatic cancer	0.000742	0.000791	CcSEcCtD
Vigabatrin—Skin disorder—Docetaxel—pancreatic cancer	0.000736	0.000785	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000735	0.000784	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—CCK—pancreatic cancer	0.000735	0.0118	CbGpPWpGaD
Vigabatrin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000731	0.000779	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000727	0.000775	CcSEcCtD
Vigabatrin—Dizziness—Irinotecan—pancreatic cancer	0.000725	0.000773	CcSEcCtD
Vigabatrin—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000721	0.000769	CcSEcCtD
Vigabatrin—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000721	0.000769	CcSEcCtD
Vigabatrin—Diarrhoea—Fluorouracil—pancreatic cancer	0.000719	0.000766	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—CNR2—pancreatic cancer	0.000716	0.0115	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—GLP1R—pancreatic cancer	0.000716	0.0115	CbGpPWpGaD
Vigabatrin—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000716	0.000763	CcSEcCtD
Vigabatrin—Oedema peripheral—Epirubicin—pancreatic cancer	0.000709	0.000756	CcSEcCtD
Vigabatrin—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000707	0.000754	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—CCKAR—pancreatic cancer	0.000705	0.0113	CbGpPWpGaD
Vigabatrin—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000701	0.000748	CcSEcCtD
Vigabatrin—Vomiting—Irinotecan—pancreatic cancer	0.000697	0.000743	CcSEcCtD
Vigabatrin—Sinusitis—Doxorubicin—pancreatic cancer	0.000696	0.000742	CcSEcCtD
Vigabatrin—Dizziness—Fluorouracil—pancreatic cancer	0.000694	0.000741	CcSEcCtD
Vigabatrin—Visual impairment—Epirubicin—pancreatic cancer	0.000694	0.000739	CcSEcCtD
Vigabatrin—Rash—Irinotecan—pancreatic cancer	0.000691	0.000737	CcSEcCtD
Vigabatrin—Dermatitis—Irinotecan—pancreatic cancer	0.000691	0.000737	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000691	0.000736	CcSEcCtD
Vigabatrin—Headache—Irinotecan—pancreatic cancer	0.000687	0.000732	CcSEcCtD
Vigabatrin—Insomnia—Docetaxel—pancreatic cancer	0.000686	0.000731	CcSEcCtD
Vigabatrin—Paraesthesia—Docetaxel—pancreatic cancer	0.000681	0.000726	CcSEcCtD
Vigabatrin—Erythema multiforme—Epirubicin—pancreatic cancer	0.00068	0.000726	CcSEcCtD
Vigabatrin—Vomiting—Gemcitabine—pancreatic cancer	0.000679	0.000724	CcSEcCtD
Vigabatrin—Somnolence—Docetaxel—pancreatic cancer	0.000674	0.000719	CcSEcCtD
Vigabatrin—Rash—Gemcitabine—pancreatic cancer	0.000673	0.000718	CcSEcCtD
Vigabatrin—Dermatitis—Gemcitabine—pancreatic cancer	0.000673	0.000717	CcSEcCtD
Vigabatrin—Eye disorder—Epirubicin—pancreatic cancer	0.000673	0.000717	CcSEcCtD
Vigabatrin—Tinnitus—Epirubicin—pancreatic cancer	0.000671	0.000715	CcSEcCtD
Vigabatrin—Headache—Gemcitabine—pancreatic cancer	0.000669	0.000713	CcSEcCtD
Vigabatrin—Vomiting—Fluorouracil—pancreatic cancer	0.000668	0.000712	CcSEcCtD
Vigabatrin—Dyspepsia—Docetaxel—pancreatic cancer	0.000667	0.000711	CcSEcCtD
Vigabatrin—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000663	0.000706	CcSEcCtD
Vigabatrin—Rash—Fluorouracil—pancreatic cancer	0.000662	0.000706	CcSEcCtD
Vigabatrin—Dermatitis—Fluorouracil—pancreatic cancer	0.000662	0.000705	CcSEcCtD
Vigabatrin—Decreased appetite—Docetaxel—pancreatic cancer	0.000659	0.000703	CcSEcCtD
Vigabatrin—Headache—Fluorouracil—pancreatic cancer	0.000658	0.000702	CcSEcCtD
Vigabatrin—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000656	0.000699	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000654	0.000698	CcSEcCtD
Vigabatrin—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000654	0.000698	CcSEcCtD
Vigabatrin—Fatigue—Docetaxel—pancreatic cancer	0.000654	0.000697	CcSEcCtD
Vigabatrin—Nausea—Irinotecan—pancreatic cancer	0.000651	0.000694	CcSEcCtD
Vigabatrin—Pain—Docetaxel—pancreatic cancer	0.000648	0.000691	CcSEcCtD
Vigabatrin—Constipation—Docetaxel—pancreatic cancer	0.000648	0.000691	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—SHH—pancreatic cancer	0.000643	0.0103	CbGpPWpGaD
Vigabatrin—Visual impairment—Doxorubicin—pancreatic cancer	0.000642	0.000684	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—PRLHR—pancreatic cancer	0.00064	0.0103	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—IAPP—pancreatic cancer	0.000635	0.0102	CbGpPWpGaD
Vigabatrin—Nausea—Gemcitabine—pancreatic cancer	0.000634	0.000677	CcSEcCtD
Vigabatrin—Mental disorder—Epirubicin—pancreatic cancer	0.00063	0.000672	CcSEcCtD
Vigabatrin—Erythema multiforme—Doxorubicin—pancreatic cancer	0.00063	0.000671	CcSEcCtD
Vigabatrin—Malnutrition—Epirubicin—pancreatic cancer	0.000626	0.000668	CcSEcCtD
Vigabatrin—Feeling abnormal—Docetaxel—pancreatic cancer	0.000625	0.000666	CcSEcCtD
Vigabatrin—Nausea—Fluorouracil—pancreatic cancer	0.000624	0.000665	CcSEcCtD
Vigabatrin—Eye disorder—Doxorubicin—pancreatic cancer	0.000622	0.000664	CcSEcCtD
Vigabatrin—Tinnitus—Doxorubicin—pancreatic cancer	0.000621	0.000662	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00062	0.000661	CcSEcCtD
Vigabatrin—Tension—Epirubicin—pancreatic cancer	0.000615	0.000655	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—PTHLH—pancreatic cancer	0.000609	0.0098	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—PTCH1—pancreatic cancer	0.000609	0.0098	CbGpPWpGaD
Vigabatrin—Nervousness—Epirubicin—pancreatic cancer	0.000608	0.000649	CcSEcCtD
Vigabatrin—Back pain—Epirubicin—pancreatic cancer	0.000606	0.000646	CcSEcCtD
Vigabatrin—Muscle spasms—Epirubicin—pancreatic cancer	0.000602	0.000642	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—SSTR3—pancreatic cancer	0.000599	0.00964	CbGpPWpGaD
Vigabatrin—Body temperature increased—Docetaxel—pancreatic cancer	0.000599	0.000639	CcSEcCtD
Vigabatrin—Abdominal pain—Docetaxel—pancreatic cancer	0.000599	0.000639	CcSEcCtD
Vigabatrin—Vision blurred—Epirubicin—pancreatic cancer	0.00059	0.00063	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—GDI2—pancreatic cancer	0.000587	0.00944	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GDI1—pancreatic cancer	0.000587	0.00944	CbGpPWpGaD
Vigabatrin—Mental disorder—Doxorubicin—pancreatic cancer	0.000583	0.000622	CcSEcCtD
Vigabatrin—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000581	0.00062	CcSEcCtD
Vigabatrin—Malnutrition—Doxorubicin—pancreatic cancer	0.00058	0.000618	CcSEcCtD
Vigabatrin—Anaemia—Epirubicin—pancreatic cancer	0.000579	0.000617	CcSEcCtD
Vigabatrin—Agitation—Epirubicin—pancreatic cancer	0.000576	0.000614	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—SSTR1—pancreatic cancer	0.000575	0.00924	CbGpPWpGaD
Vigabatrin—Tension—Doxorubicin—pancreatic cancer	0.000569	0.000607	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000566	0.00911	CbGpPWpGaD
Vigabatrin—Malaise—Epirubicin—pancreatic cancer	0.000565	0.000602	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—PPY—pancreatic cancer	0.000564	0.00907	CbGpPWpGaD
Vigabatrin—Nervousness—Doxorubicin—pancreatic cancer	0.000563	0.0006	CcSEcCtD
Vigabatrin—Vertigo—Epirubicin—pancreatic cancer	0.000563	0.0006	CcSEcCtD
Vigabatrin—Back pain—Doxorubicin—pancreatic cancer	0.000561	0.000598	CcSEcCtD
Vigabatrin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000558	0.000595	CcSEcCtD
Vigabatrin—Muscle spasms—Doxorubicin—pancreatic cancer	0.000557	0.000594	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—SST—pancreatic cancer	0.000557	0.00896	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—SSTR2—pancreatic cancer	0.000553	0.0089	CbGpPWpGaD
Vigabatrin—Cough—Epirubicin—pancreatic cancer	0.000547	0.000583	CcSEcCtD
Vigabatrin—Vision blurred—Doxorubicin—pancreatic cancer	0.000546	0.000582	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—SSTR3—pancreatic cancer	0.000544	0.00876	CbGpPWpGaD
Vigabatrin—Asthenia—Docetaxel—pancreatic cancer	0.000544	0.00058	CcSEcCtD
Vigabatrin—Convulsion—Epirubicin—pancreatic cancer	0.000543	0.000579	CcSEcCtD
Vigabatrin—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000538	0.000573	CcSEcCtD
Vigabatrin—Pruritus—Docetaxel—pancreatic cancer	0.000536	0.000572	CcSEcCtD
Vigabatrin—Anaemia—Doxorubicin—pancreatic cancer	0.000536	0.000571	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—CCKBR—pancreatic cancer	0.000534	0.00859	CbGpPWpGaD
Vigabatrin—Chest pain—Epirubicin—pancreatic cancer	0.000533	0.000569	CcSEcCtD
Vigabatrin—Arthralgia—Epirubicin—pancreatic cancer	0.000533	0.000569	CcSEcCtD
Vigabatrin—Myalgia—Epirubicin—pancreatic cancer	0.000533	0.000569	CcSEcCtD
Vigabatrin—Agitation—Doxorubicin—pancreatic cancer	0.000533	0.000568	CcSEcCtD
Vigabatrin—Anxiety—Epirubicin—pancreatic cancer	0.000531	0.000567	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.00053	0.000565	CcSEcCtD
Vigabatrin—Discomfort—Epirubicin—pancreatic cancer	0.000527	0.000562	CcSEcCtD
Vigabatrin—Malaise—Doxorubicin—pancreatic cancer	0.000523	0.000557	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—SSTR1—pancreatic cancer	0.000522	0.00839	CbGpPWpGaD
Vigabatrin—Vertigo—Doxorubicin—pancreatic cancer	0.000521	0.000555	CcSEcCtD
Vigabatrin—Diarrhoea—Docetaxel—pancreatic cancer	0.000519	0.000553	CcSEcCtD
Vigabatrin—Confusional state—Epirubicin—pancreatic cancer	0.000516	0.00055	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—CNR1—pancreatic cancer	0.000514	0.00827	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PPY—pancreatic cancer	0.000512	0.00823	CbGpPWpGaD
Vigabatrin—Oedema—Epirubicin—pancreatic cancer	0.000511	0.000545	CcSEcCtD
Vigabatrin—Infection—Epirubicin—pancreatic cancer	0.000508	0.000542	CcSEcCtD
Vigabatrin—Cough—Doxorubicin—pancreatic cancer	0.000506	0.000539	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—SSTR2—pancreatic cancer	0.000502	0.00808	CbGpPWpGaD
Vigabatrin—Convulsion—Doxorubicin—pancreatic cancer	0.000502	0.000536	CcSEcCtD
Vigabatrin—Nervous system disorder—Epirubicin—pancreatic cancer	0.000501	0.000535	CcSEcCtD
Vigabatrin—Dizziness—Docetaxel—pancreatic cancer	0.000501	0.000534	CcSEcCtD
Vigabatrin—Skin disorder—Epirubicin—pancreatic cancer	0.000497	0.00053	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—GCG—pancreatic cancer	0.000497	0.00799	CbGpPWpGaD
Vigabatrin—Arthralgia—Doxorubicin—pancreatic cancer	0.000493	0.000526	CcSEcCtD
Vigabatrin—Chest pain—Doxorubicin—pancreatic cancer	0.000493	0.000526	CcSEcCtD
Vigabatrin—Myalgia—Doxorubicin—pancreatic cancer	0.000493	0.000526	CcSEcCtD
Vigabatrin—Anxiety—Doxorubicin—pancreatic cancer	0.000492	0.000524	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.00049	0.000523	CcSEcCtD
Vigabatrin—Discomfort—Doxorubicin—pancreatic cancer	0.000488	0.00052	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—CCKBR—pancreatic cancer	0.000485	0.0078	CbGpPWpGaD
Vigabatrin—Vomiting—Docetaxel—pancreatic cancer	0.000482	0.000514	CcSEcCtD
Vigabatrin—Rash—Docetaxel—pancreatic cancer	0.000478	0.00051	CcSEcCtD
Vigabatrin—Dermatitis—Docetaxel—pancreatic cancer	0.000477	0.000509	CcSEcCtD
Vigabatrin—Confusional state—Doxorubicin—pancreatic cancer	0.000477	0.000509	CcSEcCtD
Vigabatrin—Headache—Docetaxel—pancreatic cancer	0.000475	0.000506	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—AGTR1—pancreatic cancer	0.000474	0.00762	CbGpPWpGaD
Vigabatrin—Oedema—Doxorubicin—pancreatic cancer	0.000473	0.000504	CcSEcCtD
Vigabatrin—Infection—Doxorubicin—pancreatic cancer	0.00047	0.000501	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000466	0.000497	CcSEcCtD
Vigabatrin—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000464	0.000495	CcSEcCtD
Vigabatrin—Insomnia—Epirubicin—pancreatic cancer	0.000462	0.000493	CcSEcCtD
Vigabatrin—Skin disorder—Doxorubicin—pancreatic cancer	0.00046	0.00049	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—GAST—pancreatic cancer	0.000459	0.00739	CbGpPWpGaD
Vigabatrin—Paraesthesia—Epirubicin—pancreatic cancer	0.000459	0.00049	CcSEcCtD
Vigabatrin—Somnolence—Epirubicin—pancreatic cancer	0.000455	0.000485	CcSEcCtD
Vigabatrin—Nausea—Docetaxel—pancreatic cancer	0.00045	0.00048	CcSEcCtD
Vigabatrin—Dyspepsia—Epirubicin—pancreatic cancer	0.00045	0.00048	CcSEcCtD
Vigabatrin—Decreased appetite—Epirubicin—pancreatic cancer	0.000444	0.000474	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000441	0.000471	CcSEcCtD
Vigabatrin—Fatigue—Epirubicin—pancreatic cancer	0.000441	0.00047	CcSEcCtD
Vigabatrin—Pain—Epirubicin—pancreatic cancer	0.000437	0.000466	CcSEcCtD
Vigabatrin—Constipation—Epirubicin—pancreatic cancer	0.000437	0.000466	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—SCT—pancreatic cancer	0.000435	0.00701	CbGpPWpGaD
Vigabatrin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000431	0.00046	CcSEcCtD
Vigabatrin—Insomnia—Doxorubicin—pancreatic cancer	0.000428	0.000456	CcSEcCtD
Vigabatrin—Paraesthesia—Doxorubicin—pancreatic cancer	0.000425	0.000453	CcSEcCtD
Vigabatrin—Feeling abnormal—Epirubicin—pancreatic cancer	0.000421	0.000449	CcSEcCtD
Vigabatrin—Somnolence—Doxorubicin—pancreatic cancer	0.000421	0.000448	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000418	0.000446	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—GAST—pancreatic cancer	0.000417	0.00671	CbGpPWpGaD
Vigabatrin—Dyspepsia—Doxorubicin—pancreatic cancer	0.000416	0.000444	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—CCK—pancreatic cancer	0.000415	0.00668	CbGpPWpGaD
Vigabatrin—Decreased appetite—Doxorubicin—pancreatic cancer	0.000411	0.000438	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000408	0.000435	CcSEcCtD
Vigabatrin—Fatigue—Doxorubicin—pancreatic cancer	0.000408	0.000435	CcSEcCtD
Vigabatrin—Urticaria—Epirubicin—pancreatic cancer	0.000406	0.000433	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—CNR2—pancreatic cancer	0.000405	0.00651	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000405	0.00651	CbGpPWpGaD
Vigabatrin—Pain—Doxorubicin—pancreatic cancer	0.000405	0.000431	CcSEcCtD
Vigabatrin—Constipation—Doxorubicin—pancreatic cancer	0.000405	0.000431	CcSEcCtD
Vigabatrin—Abdominal pain—Epirubicin—pancreatic cancer	0.000404	0.000431	CcSEcCtD
Vigabatrin—Body temperature increased—Epirubicin—pancreatic cancer	0.000404	0.000431	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000398	0.00641	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—SCT—pancreatic cancer	0.000395	0.00636	CbGpPWpGaD
Vigabatrin—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00039	0.000416	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000387	0.000412	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—PRLHR—pancreatic cancer	0.000378	0.00608	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CCK—pancreatic cancer	0.000377	0.00607	CbGpPWpGaD
Vigabatrin—Hypersensitivity—Epirubicin—pancreatic cancer	0.000377	0.000402	CcSEcCtD
Vigabatrin—Urticaria—Doxorubicin—pancreatic cancer	0.000376	0.000401	CcSEcCtD
Vigabatrin—Body temperature increased—Doxorubicin—pancreatic cancer	0.000374	0.000399	CcSEcCtD
Vigabatrin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000374	0.000399	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—CNR2—pancreatic cancer	0.000368	0.00591	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GLP1R—pancreatic cancer	0.000368	0.00591	CbGpPWpGaD
Vigabatrin—Asthenia—Epirubicin—pancreatic cancer	0.000367	0.000391	CcSEcCtD
Vigabatrin—Pruritus—Epirubicin—pancreatic cancer	0.000362	0.000386	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—CCKAR—pancreatic cancer	0.000362	0.00582	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—IAPP—pancreatic cancer	0.000359	0.00577	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—CXCL8—pancreatic cancer	0.000358	0.00577	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ZNRF3—pancreatic cancer	0.000356	0.00572	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—ACVR1B—pancreatic cancer	0.000356	0.00572	CbGpPWpGaD
Vigabatrin—Diarrhoea—Epirubicin—pancreatic cancer	0.00035	0.000373	CcSEcCtD
Vigabatrin—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000349	0.000372	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000344	0.00554	CbGpPWpGaD
Vigabatrin—Asthenia—Doxorubicin—pancreatic cancer	0.000339	0.000362	CcSEcCtD
Vigabatrin—Dizziness—Epirubicin—pancreatic cancer	0.000338	0.000361	CcSEcCtD
Vigabatrin—Pruritus—Doxorubicin—pancreatic cancer	0.000335	0.000357	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—SHH—pancreatic cancer	0.00033	0.0053	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—IAPP—pancreatic cancer	0.000326	0.00524	CbGpPWpGaD
Vigabatrin—Vomiting—Epirubicin—pancreatic cancer	0.000325	0.000347	CcSEcCtD
Vigabatrin—Diarrhoea—Doxorubicin—pancreatic cancer	0.000324	0.000345	CcSEcCtD
Vigabatrin—Rash—Epirubicin—pancreatic cancer	0.000322	0.000344	CcSEcCtD
Vigabatrin—Dermatitis—Epirubicin—pancreatic cancer	0.000322	0.000343	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—SSTR3—pancreatic cancer	0.000322	0.00517	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—DTX1—pancreatic cancer	0.000322	0.00517	CbGpPWpGaD
Vigabatrin—Headache—Epirubicin—pancreatic cancer	0.00032	0.000342	CcSEcCtD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	0.000318	0.00512	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—SST—pancreatic cancer	0.000315	0.00506	CbGpPWpGaD
Vigabatrin—Dizziness—Doxorubicin—pancreatic cancer	0.000313	0.000334	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—PTHLH—pancreatic cancer	0.000313	0.00503	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PTCH1—pancreatic cancer	0.000313	0.00503	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SSTR1—pancreatic cancer	0.000308	0.00496	CbGpPWpGaD
Vigabatrin—Nausea—Epirubicin—pancreatic cancer	0.000304	0.000324	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—PPY—pancreatic cancer	0.000302	0.00486	CbGpPWpGaD
Vigabatrin—Vomiting—Doxorubicin—pancreatic cancer	0.000301	0.000321	CcSEcCtD
Vigabatrin—Rash—Doxorubicin—pancreatic cancer	0.000298	0.000318	CcSEcCtD
Vigabatrin—Dermatitis—Doxorubicin—pancreatic cancer	0.000298	0.000318	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—SSTR2—pancreatic cancer	0.000297	0.00477	CbGpPWpGaD
Vigabatrin—Headache—Doxorubicin—pancreatic cancer	0.000296	0.000316	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—CNR1—pancreatic cancer	0.000291	0.00467	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCKBR—pancreatic cancer	0.000287	0.00461	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—SST—pancreatic cancer	0.000286	0.0046	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000282	0.00453	CbGpPWpGaD
Vigabatrin—Nausea—Doxorubicin—pancreatic cancer	0.000281	0.0003	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—GCG—pancreatic cancer	0.000281	0.00451	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—DTX4—pancreatic cancer	0.000269	0.00433	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GLI1—pancreatic cancer	0.000269	0.00433	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000268	0.00431	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CNR1—pancreatic cancer	0.000264	0.00424	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NRP1—pancreatic cancer	0.000262	0.00422	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000262	0.00422	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—GCG—pancreatic cancer	0.000255	0.0041	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HEY2—pancreatic cancer	0.000252	0.00406	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GAST—pancreatic cancer	0.000246	0.00396	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000243	0.00391	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000239	0.00385	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SCT—pancreatic cancer	0.000234	0.00376	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HEY1—pancreatic cancer	0.000234	0.00376	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCK—pancreatic cancer	0.000223	0.00359	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CNR2—pancreatic cancer	0.000217	0.00349	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GLP1R—pancreatic cancer	0.000217	0.00349	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000217	0.00349	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—HRAS—pancreatic cancer	0.000216	0.00347	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCKAR—pancreatic cancer	0.000214	0.00344	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—JAG2—pancreatic cancer	0.000207	0.00333	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MEN1—pancreatic cancer	0.000204	0.00328	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SHH—pancreatic cancer	0.000195	0.00313	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000194	0.00311	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IAPP—pancreatic cancer	0.000192	0.00309	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PTHLH—pancreatic cancer	0.000185	0.00297	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PTCH1—pancreatic cancer	0.000185	0.00297	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—HRAS—pancreatic cancer	0.000183	0.00295	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SST—pancreatic cancer	0.000169	0.00272	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000167	0.00268	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—JAG1—pancreatic cancer	0.000165	0.00266	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000165	0.00265	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CNR1—pancreatic cancer	0.000156	0.00251	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000151	0.00243	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—GCG—pancreatic cancer	0.000151	0.00242	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000146	0.00236	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AGTR1—pancreatic cancer	0.000144	0.00231	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—STK11—pancreatic cancer	0.000142	0.00228	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000133	0.00214	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000128	0.00205	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SMAD4—pancreatic cancer	0.000124	0.00199	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000123	0.00197	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HES1—pancreatic cancer	0.000121	0.00195	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000116	0.00186	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CXCL8—pancreatic cancer	0.000111	0.00179	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TERT—pancreatic cancer	0.000106	0.00171	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HIF1A—pancreatic cancer	0.000101	0.00163	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TSC2—pancreatic cancer	0.000101	0.00163	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—APOE—pancreatic cancer	9.9e-05	0.00159	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—KDR—pancreatic cancer	9.7e-05	0.00156	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NFKBIA—pancreatic cancer	9.23e-05	0.00148	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NOTCH1—pancreatic cancer	9.14e-05	0.00147	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PIK3CG—pancreatic cancer	8.94e-05	0.00144	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—NRAS—pancreatic cancer	8.94e-05	0.00144	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—EGF—pancreatic cancer	8.83e-05	0.00142	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—EGFR—pancreatic cancer	8.14e-05	0.00131	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PIK3CD—pancreatic cancer	7.86e-05	0.00126	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—PIK3CA—pancreatic cancer	7.78e-05	0.00125	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—KRAS—pancreatic cancer	7.69e-05	0.00124	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—PIK3CA—pancreatic cancer	7.07e-05	0.00114	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PIK3CB—pancreatic cancer	6.85e-05	0.0011	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CXCL8—pancreatic cancer	6.58e-05	0.00106	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—HRAS—pancreatic cancer	6.54e-05	0.00105	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—AKT1—pancreatic cancer	6.36e-05	0.00102	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CASP3—pancreatic cancer	6.3e-05	0.00101	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCND1—pancreatic cancer	6.13e-05	0.000986	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CTNNB1—pancreatic cancer	6.07e-05	0.000977	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MMP9—pancreatic cancer	5.95e-05	0.000957	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PTEN—pancreatic cancer	5.92e-05	0.000952	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—AKT1—pancreatic cancer	5.77e-05	0.000929	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SRC—pancreatic cancer	5.49e-05	0.000883	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—VEGFA—pancreatic cancer	5.34e-05	0.00086	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—STAT3—pancreatic cancer	5.29e-05	0.000851	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—NRAS—pancreatic cancer	5.28e-05	0.000849	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MYC—pancreatic cancer	4.92e-05	0.000791	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TGFB1—pancreatic cancer	4.91e-05	0.000789	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—EGFR—pancreatic cancer	4.81e-05	0.000774	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—KRAS—pancreatic cancer	4.54e-05	0.000731	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PIK3CA—pancreatic cancer	4.17e-05	0.000671	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TP53—pancreatic cancer	4.04e-05	0.00065	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—HRAS—pancreatic cancer	3.86e-05	0.000621	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—AKT1—pancreatic cancer	3.41e-05	0.000549	CbGpPWpGaD
